KFC
AGN

Klingenstein Fields & Co’s Allergan plc AGN Stock Holding History

Klingenstein Fields & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,533
Closed -$373K – 226
2017
Q2 		$373K Buy
1,533
+88
+6% +$20.7K 0.01% 164
2017
Q1 		$345K Buy
+1,445
New +$337K 0.01% 167
2016
Q4 		– Sell
-990
Closed -$228K – 239
2016
Q3 		$228K Sell
990
-150
-13% -$36.7K 0.01% 206
2016
Q2 		$263K Buy
+1,140
New +$263K 0.01% 187
2016
Q1 		– Sell
-900
Closed -$281K – 220
2015
Q4 		$281K Hold
900
– – 0.01% 186
2015
Q3 		$245K Sell
900
-569
-39% -$175K 0.01% 197
2015
Q2 		$446K Hold
1,469
– – 0.02% 160
2015
Q1 		$437K Buy
+1,469
New +$419K 0.02% 169

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Klingenstein Fields & Co's AGN Position: Q3 2017 in Review

Klingenstein Fields & Co sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 1,533 shares — an estimated $373K sold.

Klingenstein Fields & Co first reported a position in AGN in Q1 2015 and held it in 8 quarters. The position peaked at $446K in Q2 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Klingenstein Fields & Co reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Klingenstein Fields & Co sold 1,533 Allergan plc shares in Q3 2017, an estimated $373K.
  • Klingenstein Fields & Co first reported a position in Allergan plc in Q1 2015 and held it in 8 quarters.
  • Klingenstein Fields & Co's Allergan plc position peaked at $446K in Q2 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Klingenstein Fields & Co's 13F filing for Q3 2017, filed 1 Nov 2017.